Targeting cancer with nano-bullets: curcumin, EGCG, resveratrol and quercetin on flying carpets

Area of Science:

• Phytochemistry
• Molecular Oncology
• Nanomedicine

Background:

• Phytochemicals from edible plants target specific carcinogenesis stages.
• Cancer cells evade apoptosis via altered gene expression and signaling pathways.
• Molecular alterations drive cancer progression, including metastasis.

Purpose of the Study:

• To review the anticancer potential of key phytochemicals: curcumin, EGCG, resveratrol, and quercetin.
• To explore how nanotechnology enhances the bioavailability of these compounds.
• To understand the impact of improved bioavailability on therapeutic efficacy.

Main Methods:

• In vitro studies assessing phytochemical anticancer activity.
• In vivo testing in tumor xenograft mouse models.
• Review of nanotechnology-based strategies for enhancing phytochemical bioavailability.

Main Results:

• Curcumin, EGCG, resveratrol, and quercetin demonstrate significant promise as anticancer agents.
• Nanotechnology approaches have shown success in improving the bioavailability of these phytochemicals.
• Enhanced bioavailability is crucial for maximizing the therapeutic effects of these compounds.

Conclusions:

• Phytochemicals represent a viable strategy for cancer therapy.
• Nanotechnology offers a powerful tool to overcome bioavailability limitations of natural anticancer compounds.
• Further research into nano-formulated phytochemicals could lead to improved cancer treatments.